University of North Dakota

UND Scholarly Commons
Physician Assistant Scholarly Project Posters

Department of Physician Studies

2015

Effects of Saw Palmetto on Lower Urinary Tract
Symptoms From Benign Prostatic Hyperplasia
Michael Trimble
University of North Dakota

Follow this and additional works at: https://commons.und.edu/pas-grad-posters
Part of the Alternative and Complementary Medicine Commons, and the Urology Commons
Recommended Citation
Trimble, Michael, "Effects of Saw Palmetto on Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia" (2015). Physician
Assistant Scholarly Project Posters. 102.
https://commons.und.edu/pas-grad-posters/102

This Poster is brought to you for free and open access by the Department of Physician Studies at UND Scholarly Commons. It has been accepted for
inclusion in Physician Assistant Scholarly Project Posters by an authorized administrator of UND Scholarly Commons. For more information, please
contact zeineb.yousif@library.und.edu.

Effects Of Saw Palmetto On Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia
Michael Trimble, PA-S, RPA, RRA, R.T. (R)(CV)
Department of Physician Assistant Studies, University of North Dakota School of Medicine and Health Sciences
Grand Forks, North Dakota 58202-9037

Abstract
• Benign prostatic hypertrophy (BPH) is common in older males
and can cause lower urinary tract symptoms (LUTS).
• Saw Palmetto, an herbal supplement, is normally implemented
as an alternative medication to treat lower urinary tract
symptoms associated with BPH.
• The review of literature evaluated studies comparing the effects
and outcomes of Saw Palmetto versus commonly prescribed
medications such as antiadrenergic agents.

Literature Review
• BPH consists of prostatic stromal/epithelial remodeling.
• Age is the most commonly related risk factor at 50% in men at
age 60 and 90% in men age 70 and older.
• Changes in dihydrotestosterone (DHT) and 5alpha-reductase in
the epithelium and stroma are thought to disrupt the balance of
growth factor signaling and epithelial/stromal interactions
resulting in excessive growth and tissue hyperplasia.

Discussion

Applicability to Clinical Practice

• Lipidosterolic extracts from Saw Palmetto decrease prostatic
cellular viability and down regulate gene expression affecting
prostatic cellular apoptosis, proliferation pathways, and
inflammation pathways which reduce the pathogenesis of BPH.
(Sirab et al., 2013).

• There are conflicting studies indicating Saw Palmetto’s efficacy
on LUTS and reducing BPH.

• Prostataplex (Saw Palmetto) has a short term improvement on
LUTS, but it does not affect prostate hyperplasia.
(Shi et al., 2008).

• The prostatic periurethral area is common for BPH resulting in
compression and gradual lower urinary tract symptoms (LUTS).

• Conversely, Iglesias-Gato etal., 2011, found that a minimum
concentration of 50 ug/mL of Prostasan (Saw Palmetto)
inhibited prostatic hyperplasia.

• Saw Palmetto has no side effects, and is available at a low cost
when compared to prescribed medications for BPH.

• Gene expression of 2 types of inhibitors of apoptosis proteins
(IAPs), neuronal apoptosis inhibitor protein (NAIP) and
survivin, increase BPH. (Minutoli et al., 2014).

• Saw Palmetto at a dosage of 960 mg did not reduce LUTS
associated with BPH versus placebo. (Barry et al., 2011).

Introduction

• Cell viability assays showed that the lipidosterolic extract of
Saw Palmetto had prostatic epithelial/stromal cytotoxic effects
resulting in a 100% decrease in cell viability at doses of
100ug/mL and greater. (Sirab et al., 2013).

• There are conflicting studies indicating Saw Palmetto’s
efficacy on lower urinary tract symptoms and reduction of BPH.

• The objective for providers is to prescribe or recommend a
medication that is effective and affordable with low side effects
for LUTS associated with BPH.
• Mild LUTS are treatable with prescribed medications such as
antiadrenergic agents.
• An alternative phytotherapeutic option, Saw Palmetto, is also
available which may be effective on LUTS associated with
BPH, may be financially beneficial and may have less side
effects.

Statement of the Problem

• Saw Palmetto (Prostasan), at 50ug/mL, can inhibit proliferative
functions of endothelial growth factor and inhibit cytokine
production on prostatic PC-3 cells. (Iglesias-Gato et al., 2011).

Discussion

• There were no statistically significant differences with the
AUASI scores and the peak urinary flow rates between the Saw
Palmetto and placebo groups, so Saw Palmetto did not reduce
LUTS associated with BPH. (Bent et al., 2006).
• Saw Palmetto does not produce any side effects when taken for
up to 18 months. (Avins et al., 2013).
• Saw Palmetto at a dosage of 960 mg does not cause side effects.
(Barry et al., 2011).
• The combination of Tamsulosin with Saw Palmetto may cause
postural hypotension, fatigue, rhinitis, ejaculation disorders,
decreased libido, and dry mouth. There were no adverse effects
observed with Saw Palmetto alone. (Hizli et al., 2006).

• An experimental trial found that Saw Palmetto, combined with
Selenium and Lycopene, has a greater effect on BPH versus
implementing either treatment alone.
(Minutoli et al., 2014).

• Few studies have researched the outcomes of Saw Palmetto.
• Many patients have concerns with increased cost and side
effects with prescribed medications.
• Some religious or cultural concerns prohibit use of prescribed
medications, so preferences for viable alternative
phytotherapeutic options may exist.

Research Questions
• Is Saw Palmetto, an herbal supplement, an effective
phytotherapeutic alternative to commonly prescribed
medications in treating LUTS associated with BPH?
• Is Saw Palmetto cost effective?
• Is there less toxicity associated with Saw Palmetto in
comparison to prescribed medications?
• Is Saw Palmetto a viable alternative phytotherapeutic option
among culturally/religiously diverse patients?

• Prostataplex has a short term improvement on LUTS, but does
not affect BPH.
• Prostasan may inhibit BPH.
• Saw Palmetto combined with Selenium and Lycopene may have
a greater effect on BPH than Saw Palmetto alone.
• Saw Palmetto is inexpensive and has no side effects.
• It is reasonable, with patients that have resisted or discontinued
prescription medications, to discuss the option of Saw Palmetto
although it may or may not lower LUTS and/or reduce BPH.
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• The maximal urinary flow rate (Qmax) was greater with the
combination of Saw Palmetto and Tamsulosin (Flomax)
compared to either medication used alone. (Hizli et al., 2007).

• Prostataplex (Saw Palmetto) was a preferred option because of
low cost and lower toxicity compared to prescription
medication. (Shi et al., 2008).

• Decreases in PSA levels were similar (0.2) in all groups and
were not statistically significant. (Hizli et al., 2007).

• Alternative phytotherapeutic agents are increasingly
implemented because patients are unsatisfied with prescribed
medications and because of diverse cultural/religious values
and beliefs. (Hizli et al., 2006).
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